-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
INTERCEPT PHARMACEUTICALS, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2013 to Q3 2023.
- INTERCEPT PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 41.8M shares, a 21.9% increase year-over-year.
- INTERCEPT PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 33.8M shares, a 6.09% increase from 2021.
- INTERCEPT PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 31.9M shares, a 3.26% decline from 2020.
- INTERCEPT PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 33M shares, a 4.16% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)